Nolet Chris

CIK 00017828145 companiesNEWTOWN SQUARE, PA

SEC Profile

Transactions

Companies

Filings

CIK

0001782814

Recent Transactions

31 trades

Award
Jasper Therapeutics, Inc.$JSPR
Stock Option (right to buy)
2025-07-03+7,500→ 7,500 total
Award
ArriVent BioPharma, Inc.$AVBP
Non-Qualified Stock Option (right to buy)
2025-06-18+15,502→ 15,502 total
Disposition to Issuer
Revance Therapeutics, Inc.
Common Stock
2025-02-06−15,000→ 0 total
Disposition from Tender
Revance Therapeutics, Inc.
Common Stock
2025-02-04$3.65/sh−28,606→ 15,000 total
Award
Jasper Therapeutics, Inc.$JSPR
Stock Option (right to buy)
2024-06-06+7,500→ 7,500 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2024-05-01+23,458→ 23,458 total
Award
Revance Therapeutics, Inc.
Common Stock
2024-05-01+15,000→ 43,606 total
Award
ArriVent BioPharma, Inc.$AVBP
Stock Option (right to buy)
2024-01-25+17,884→ 17,884 total
Award
Jasper Therapeutics, Inc.$JSPR
Stock Option (right to buy)
2023-06-07+47,000→ 47,000 total
Award
Revance Therapeutics, Inc.
Common Stock
2023-05-03+3,534→ 28,606 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2023-05-03+5,915→ 5,915 total
Exercise/Conversion
POLARITYTE, INC.
Common Stock
2023-01-12−36,497→ 14,403 total
Exercise/Conversion
POLARITYTE, INC.
Stock option (right to buy)
2023-01-12−3,078→ 6,157 total
Award
Jasper Therapeutics, Inc.$JSPR
Voting Common Stock
2022-10-12+32,500→ 32,500 total
Award
POLARITYTE, INC.
Common Stock
2022-10-01+50,900→ 50,900 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2022-05-04+10,756→ 10,756 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2022-05-04+11,343→ 11,343 total
Award
Revance Therapeutics, Inc.
Common Stock
2022-05-04+6,059→ 25,072 total
Award
Jasper Therapeutics, Inc.$JSPR
Stock Option (right to buy)
2022-03-21+78,045→ 78,045 total
Award
Revance Therapeutics, Inc.
Common Stock
2021-05-05+4,013→ 19,013 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2021-05-05+7,551→ 7,551 total
Disposition to Issuer
Viela Bio, Inc.
Stock Option (right to buy)
2021-03-15−26,210→ 0 total
Disposition to Issuer
Viela Bio, Inc.
Stock Option (right to buy)
2021-03-15−7,358→ 0 total
Award
POLARITYTE, INC.
Stock option (Right to Buy)
2021-01-01$0.48/sh+166,443→ 166,443 total
Award
Viela Bio, Inc.
Stock Option (right to buy)
2020-06-19+7,358→ 7,358 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2020-05-14+12,000→ 12,000 total
Award
Revance Therapeutics, Inc.
Common Stock
2020-05-14+6,000→ 15,000 total
Award
POLARITYTE, INC.
Stock Option (right to buy)
2020-04-06+230,894→ 230,894 total
Award
Viela Bio, Inc.
Stock Option (right to buy)
2019-10-02+26,210→ 26,210 total
Award
Revance Therapeutics, Inc.
Common Stock
2019-07-16+9,000→ 9,000 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2019-07-16+18,000→ 18,000 total

Companies

Recent Filings

Address

C/O ARRIVENT BIOPHARMA, INC. 18 CAMPUS BOULEVARD SUITE 100

NEWTOWN SQUARE, PA, 19073

View on SEC.gov